CD133, a novel marker for human prostatic epithelial stem cells
- PMID: 15226377
- DOI: 10.1242/jcs.01222
CD133, a novel marker for human prostatic epithelial stem cells
Abstract
Stem cells are clonogenic cells with self-renewal and differentiation properties, which may represent a major target for genetic damage leading to prostate cancer and benign prostatic hyperplasia. Stem cells remain poorly characterised because of the absence of specific molecular markers that permit us to distinguish them from their progeny, the transit amplifying cells, which have a more restricted proliferative potential. Human CD133 antigen, also known as AC133, was recently identified as a haematopoietic stem cell marker. Here we show that a small population (approximately 1%) of human prostate basal cells express the cell surface marker CD133 and are restricted to the alpha(2)beta(1)(hi) population, previously shown to be a marker of stem cells in prostate epithelia. alpha(2)beta(1)(hi)/CD133(+) cells exhibit two important attributes of epithelial stem cells: they possess a high in vitro proliferative potential and can reconstitute prostatic-like acini in immunocompromised male nude mice.
Similar articles
-
The characterization of epithelial and stromal subsets of candidate stem/progenitor cells in the human adult prostate.Eur Urol. 2008 Mar;53(3):524-31. doi: 10.1016/j.eururo.2007.11.028. Epub 2007 Nov 21. Eur Urol. 2008. PMID: 18053634
-
Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.PLoS One. 2012;7(11):e48944. doi: 10.1371/journal.pone.0048944. Epub 2012 Nov 7. PLoS One. 2012. PMID: 23145034 Free PMC article.
-
Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate.Prostate. 2011 Feb 15;71(3):254-67. doi: 10.1002/pros.21239. Epub 2010 Aug 17. Prostate. 2011. PMID: 20717901
-
Novel human prostate epithelial cell culture models for the study of carcinogenesis and of normal stem cells and cancer stem cells.Adv Exp Med Biol. 2011;720:71-80. doi: 10.1007/978-1-4614-0254-1_6. Adv Exp Med Biol. 2011. PMID: 21901619 Review.
-
CD133(+) cells isolated from various sources and their role in future clinical perspectives.Expert Opin Biol Ther. 2010 Nov;10(11):1521-8. doi: 10.1517/14712598.2010.528386. Epub 2010 Oct 11. Expert Opin Biol Ther. 2010. PMID: 20932225 Review.
Cited by
-
Dermal Papilla Cells: From Basic Research to Translational Applications.Biology (Basel). 2024 Oct 20;13(10):842. doi: 10.3390/biology13100842. Biology (Basel). 2024. PMID: 39452150 Free PMC article. Review.
-
Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease.Cell Mol Biol Lett. 2024 Mar 26;29(1):41. doi: 10.1186/s11658-024-00554-0. Cell Mol Biol Lett. 2024. PMID: 38532366 Free PMC article. Review.
-
Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons.Int J Mol Sci. 2023 Dec 12;24(24):17398. doi: 10.3390/ijms242417398. Int J Mol Sci. 2023. PMID: 38139228 Free PMC article. Review.
-
Shotgun Proteomic-Based Approach with a Q-Exactive Hybrid Quadrupole-Orbitrap High-Resolution Mass Spectrometer for Protein Adductomics on a 3D Human Brain Tumor Neurospheroid Culture Model: The Identification of Adduct Formation in Calmodulin-Dependent Protein Kinase-2 and Annexin-A1 Induced by Pesticide Mixture.J Proteome Res. 2023 Dec 1;22(12):3811-3832. doi: 10.1021/acs.jproteome.3c00484. Epub 2023 Oct 31. J Proteome Res. 2023. PMID: 37906427 Free PMC article.
-
Prostate Cancer Stem Cells: Biology and Treatment Implications.Int J Mol Sci. 2023 Oct 4;24(19):14890. doi: 10.3390/ijms241914890. Int J Mol Sci. 2023. PMID: 37834336 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials